Authors: Erdmann, E Lechat, P Verkenne, P Wiemann, H

Citation: E. Erdmann et al., Results from post-hoc analyses of the CIBIS II trial: effect of bisoprololin high-risk patient groups with chronic heart failure, EUR J HE FA, 3(4), 2001, pp. 469-479

Authors: Bacquet, P Levy, E McGuire, A McMurray, J Merot, JL Paschen, B Remme, WJ Szucs, TD Klein, W Brunhuber, W Hofmann, R Kuhn, P Nesser, HJ Slany, J Weihs, W Wiedermann, C Wimmer, H van Mieghem, W Boland, J Chaudron, JM Jordaens, L Melchior, JP Aschermann, M Bruthansl, J Hradec, M Kolbel, F Semrad, B Haghfelt, T Hansen, JF Goetzsche, CO Hildebrandt, P Kassis, E Rasmussen, V Rokkedal, J Thomassen, A Groundstroem, K Uusimaa, P Le Heuzey, JY Aumont, MC Aupetit, JF Baille, N Baudouy, P Belin, A Bonneau, A Bonneric, G Bousser, JP Citron, B Dary, P Decoulx, E De Groote, P Denolle, T Dievart, F Duriez, P Eicher, JC Enjuto, G Ferriere, M Fournier, E Garandeau, M Gauthier, J Genest, M Gerbe, A Godenir, JP Guillot, B Guillot, JP Guillot, P Heno, P d'Ivernois, C Jean, M Kacet, S Kalle, R Komajda, M Lacroix, A Lallemand, R Lardoux, H Marquet, M Martin, M Martin, O Mery, D Mossaz, R Mothes, P Olive, T Ostorero, M Paganelli, F Page, E Pauly-Laubry, C Puel, J Rousseau, JF Roux, JJ Schenowitz, A Sourdais, K Tremel, F Verdun, A Witchiz, S Wolf, JE Hombach, V Assmann, I Beyer, T Bischoff, KO Darius, H Ertl, G Fleck, E Forster, K Freytag, F Gleichmann, U Haasis, R Henssge, R Hey, D Hesse, P Hofs, T Keck, M Klein, H Kromer, ET Kruls-Munch, J Luderitz, B Maisch, B Mitrovic, V Neubauer, S Osterziel, KJ Simon, H Spitzer, SG Stohring, R Taubert, G Teichmann, W Theisen, K Wende, W Wieser, H Zotz, R Bridges, A Adgey, J Ambepitiya, G Boon, N Boyle, RM Cowley, AJ Cripps, T Davies, MK Dunn, F Findlay, J Forsey, P Fyfe, T Gould, B Greenwood, TW Hubner, P Khan, S Lewis, P Mackay, A Maltz, M McArthur, J McLeod, A McLeod, D Metcalfe, M Millar-Craig, M Mills, P Nelson, JK Nicholls, D Oakley, GD Patterson, DLH Pohl, JEF Ray, S Silke, B Wilkinson, PR Preda, I Csanady, M Cserhalmi, L Edes, I Gesztesi, T Karpati, P Simon, K Tarjan, J Fogari, R Tramarin, R Galie, N Giani, P Milanese, U Scalvini, S Scrutinio, D Sechi, LA Tettamanti, F De Vito, F Crean, P McCann, H Mulcahy, D Sugrue, D van Hoogenhuyze, DCA van der Burgh, PH Ciampricotti, R van Dantzig, JM DenHartog, FR Henneman, JA van Kesteren, HAM Kragten, JA Liem, KL Limburg, A van der Linde, MR Linssen, GCM Pasteuning, H Penn, HJAM Van Rossum, P Schaafsma, HJ Schelling, A Sloos, R Wesdorp, JCL Korewicki, J Achremczyk, P Czestockowska, E Dowgird, M Dyduszynski, A Gorski, J Ilmurzynska, K Janicki, K Kornacewicz-Jach, Z Kraska, T Krzeminska-Pakula, M Kuch, J Nartowicz, E Petelenz, T Piwowarska, W Rawczynska-Englert, I Ruzyllo, W Swiatecka, G Tendera, M Wierzchowiecki, M Wodniecki, J Wojciechowoski, D Wrabec, K Wysocki, H Gomes, RS Ceia, MF Lousada, N Campos, JMM Providencia, LA de Moura, ALZC Marejev, VJ Aronov, DM Arutjunov, GP Bart, BJ Basechikin, SS Belenkov, JN Beloussov, JB Bokeria, OA Charchogljan, RA Doschytsin, V Fedorova, TA Glezer, MG Gorbachenkov, A",Gorshkov,"Gospodarenko, AL Ivashkin, VT Ivleva, AJ Kyrichenko, AA Lavrov, AA Lazebnik, LB Marynov, A Mazaev, VP Polejev, NR",Shpektor,"Sidorenko, BA Sobolev, KE Starodoubtsev, AK Storozhakhov, GI Syrkin, AL Zodionchenko, VS Zvereva, TV Murin, J Kaliska, G Rybar, R Valle, V Artaza, M Conthe, P Cruz, JM Garcia-Moll, M Lopez-Sendon, JL Martinez, A Monzon, F Ribas, M Roig, E Roldan, I Hoglund, C Ekdahl, S Hjelmaeus, L Lindberg, K Lofdahl, P Ulvenstam, G Warselius, L Follath, F Anghern, W Dubach, P Erne, P Gallino, A Moccetti, T Jmouro, AV Dargie, HJ Erdmann, E Follath, F Hoglund, C Lechat, P Sendon, JLL Mareyev, V Remme, WJ Sadowski, Z Seabra-Gomes, RJ Zannad, F Wehrlen-Grandjean, M Funck-Brentano, C Hansen, S Hohnloser, S Vanoli, E Jaillon, P De Baker, G Dahlstrom, U Hill, C Leizorovicz, A Burgnard, F Rolland, C Wiemann, H Verkenne, P Arab, T Cussac, N Dussous, V Haise, S Funck-Brentano, C

Citation: P. Bacquet et al., Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II), EUR HEART J, 22(12), 2001, pp. 1021-1031